What is NDC 17156-067?

17156-067 is the product NDC for Vizamyl (flutemetamol f-18), Flutemetamol f-18 4.05 mCi/mL solution, listed with the FDA by GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare). It has 1 package NDC, shown above in 10- and 11-digit form.

GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare), NDC labeler code 17156. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Vizamyl?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Vizamyl NDC 17156-067 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)17156-067Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17156-0067Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
17156-067-30	17156006730	1 VIAL, MULTI-DOSE in 1 CONTAINER (17156-067-30) / 30 mL in 1 VIAL, MULTI-DOSEMarketed from Mar 1, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vizamyl
Generic name (nonproprietary): flutemetamol f-18
Active ingredients: Flutemetamol f-18 — 4.05 mCi/mL
Dosage form: Solution
Route: Intravenous
Labeler: GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)NDC labeler code 17156
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 203137
Marketing start: Jan 1, 2014
Listing expires: Dec 31, 2027
Other FDA classes: Radiopharmaceutical Activity (Mechanism)
Identifiers: Product ID 17156-067_4fda8ebc-b46e-4d12-9c45-8cbb3a2516bbSPL ID 4fda8ebc-b46e-4d12-9c45-8cbb3a2516bbSPL set ID b3558f16-8f9a-4e55-8d9c-836427ebaa57UNII L49M066S0O
Pharmacologic class: Radioactive Diagnostic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N417156006730 followed by a unit qualifier and the quantity

Package 17156-0067-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 6, 2026.

Indications (excerpt from the label)

VIZAMYL is indicated for positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information of the therapeutic products VIZAMYL is a radioactive diagnostic drug indicated for positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline Selection of patients who are indicated for …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 17156-067

What is NDC 17156-067?: 17156-067 is the product NDC for Vizamyl (flutemetamol f-18), Flutemetamol f-18 4.05 mCi/mL solution, listed with the FDA by GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare). It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Vizamyl (Flutemetamol F-18).
What is the active ingredient?: Flutemetamol f-18.
Who is the labeler?: GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare), NDC labeler code 17156. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vizamyl?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Vizamyl (Flutemetamol f-18) NDC 17156-067